SEC Form 4 · accession 0001567619-19-000984
Kura Oncology, Inc. · KURA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
EcoR1 Capital Fund Qualified, L.P.
10% Owner
Period of report
Dec 17, 2018
Accepted (ET)
Jan 10, 2019 · 6:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2018 | S | 26,520 | $13.20 | D | 4,194,209 | D | |
| Common Stock | Dec 18, 2018 | P | 78,469 | $13.82 | A | 4,272,678 | D | |
| Common Stock | Dec 19, 2018 | P | 51,879 | $13.84 | A | 4,324,557 | D | |
| Common Stock | Dec 21, 2018 | P | 83,540 | $13.16 | A | 4,408,097 | D |
Table II — derivative securities
No Table II lines on this filing.